rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anthony D'Adamio

SVP & General Counsel

Company insider

Files Form 4 as: SVP & General Counsel, Bioventus.

In numbers

Trades disclosed
80
Buys
1
Sells
11
Bought
$13K
Sold
$484K
Companies
1
Companies where not an officer
0
First trade
11 Feb 2021
Last trade
10 Apr 2026
Last filed
14 Apr 2026

Companies traded

Where they are an officer
BVS BioventusOfficer · Medical Devices · last 10 Apr 20261 buy · 11 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Apr 2026filed 14 Apr 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—9,925 at $0.00filing
10 Apr 2026filed 14 Apr 2026BVS BioventusMedical DevicesSEC FORM 4 Code F$39K4,312 at $9.06filing
10 Apr 2026filed 14 Apr 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—9,925 at $0.00filing
10 Apr 2026filed 14 Apr 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—9,925 at $0.00filing
10 Apr 2026filed 14 Apr 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—9,925 at $0.00filing
10 Apr 2026filed 14 Apr 2026BVS BioventusMedical DevicesSEC FORM 4 Code F$39K4,312 at $9.06filing
13 Mar 2026filed 17 Mar 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—8,886 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—8,750 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS BioventusMedical DevicesSEC FORM 4 Code F$33K3,861 at $8.62filing
13 Mar 2026filed 17 Mar 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—8,750 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—83,000 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—92,000 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—8,886 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code M—8,750 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS BioventusMedical DevicesSEC FORM 4 Code F$33K3,802 at $8.62filing
13 Mar 2026filed 17 Mar 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—83,000 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS Bioventusoption or derivative · Medical DevicesSEC FORM 4 Code A—92,000 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—8,886 at $0.00filing
13 Mar 2026filed 17 Mar 2026BVS BioventusMedical DevicesSEC FORM 4 Code F$33K3,861 at $8.62filing
13 Mar 2026filed 17 Mar 2026BVS BioventusMedical DevicesSEC FORM 4 Code M—8,750 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care12

Buys in green, sells in red, by the company’s sector.

Related people

Martin P. SutterDirector and 10% owner · Director and 10% owner at Bioventus, filing Form 4 there in the last year
William A. HawkinsDirector · Director at Bioventus, filing Form 4 there in the last year
Guy P. NohraDirector · Director at Bioventus, filing Form 4 there in the last year
Philip G. CowdyDirector · Director at Bioventus, filing Form 4 there in the last year
Mary Kay LadoneDirector · Director at Bioventus, filing Form 4 there in the last year